
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HS3ST1 CRISPR/Cas9 KO Plasmid (h) | sc-405358 | 20 µg | $397.00 |
HS3ST1 encodes heparan sulfate-glucosamine 3-O-sulfotransferase 1, a Golgi-localized enzyme that catalyzes 3-O-sulfation of heparan sulfate chains, generating rare motifs that modulate protein–glycosaminoglycan interactions. By shaping heparan sulfate fine structure, HS3ST1 influences extracellular matrix organization and cell-surface co-receptor functions that tune signaling pathways involving growth factors, chemokines, and morphogens. Altered heparan sulfate sulfation patterns are linked to changes in cell adhesion, migration, and inflammatory signaling, processes frequently implicated in tumor biology and neurodevelopmental phenotypes. As a determinant of heparan sulfate structure, HS3ST1 is studied for its role in regulating ligand binding and downstream signaling dynamics across diverse cellular contexts.
HS3ST1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the HS3ST1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the HS3ST1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the HS3ST1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish HS3ST1 protein expression.
This CRISPR knockout system enables efficient generation of HS3ST1-deficient cell models for investigation of HS3ST1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.